Search Results 681-690 of 19154 for creatinine

  1. Bendamustine Hydrochloride and Rituximab with or without Bortezomib Followed by Rituximab with or without Lenalidomide in Treating Patients with High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma - Mayo Clinic

    Creatinine ≤ 2.0 mg/dL; AST and ALT ≤ 5 x upper limit of normal (ULN); Alkaline phosphatase ≤ 5 x ULN; Total bilirubin ≤ 1.5 x ULN (patients with known ...

  2. A Study of AbGn-107 in Patients With Gastric, Colorectal, or Pancreatic Cancer - Mayo Clinic

    Serum creatinine ≤1.5 x upper limit of normal (ULN) or a calculated creatinine clearance >60 mL/min,; Total bilirubin <1.5 x ULN, except for patients ...

  3. Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas - Mayo Clinic

    - Serum creatinine ≤ ULN or creatinine clearance ≥ 60 mL/min/1.73 m^2 by Cockcroft-Gault for patients; - Serum total bilirubin ≤ 1.5 ULN; - AST(SGOT)/ALT ...

  4. Phase I Study Of BL0020, A Novel Anti-tumor Drug, In Adult Subjects With Advanced Solid Tumors - Mayo Clinic

    * Creatinine \> 1.5×ULN or creatinine clearance \< 50 mL/min. 16. Those who are known to be allergic to the active ingredient or excipients of the ...

  5. Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone - Mayo Clinic

    Serum Creatinine < 2.0 mg/dL [176.8 µmol/liter];; Serum calcium ≤ 11.5 mg/dL;; Calc. Creatinine Clearance > 50 mL/min;; Bilirubin ≤ 1.5 x upper limits of ...

  6. VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM - Mayo Clinic

    Serum creatinine ≤1.5 x upper limit of normal or creatinine clearance >60 mL/min (measured or calculated by the Cockcroft-Gault formula) (Cockcroft DW et al, ...

  7. Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy - Mayo Clinic

    Serum Creatinine ≤2.0 mg/dL; Serum glutamic oxaloacetic transaminase (SGOT) or Serum glutamic oxaloacetic transaminase (SGPT) ≤3 x Upper Limit of Normal ...

  8. A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis - Mayo Clinic

    ... creatinine > 2.5 milligram per deciliter (mg/dL) (>221 µmol/L) or rise in creatinine > 2 mg/dL (>177 µmol/L) over a 48 hour period; Severe gastrointestinal ...

  9. A Study of the Effect of Vedolizumab in Conjunction with Structured Semi-Vegetarian Diet on the Treatment of Ulcerative Colitis - Mayo Clinic

    ... creatinine >2 × ULN; Antibiotic use within past 14 days; Probiotics use within past 7 days. Participating Mayo Clinic locations. Study statuses change often ...

  10. Acamprosate Treatment Outcome - Clinical Trials

    Renal impairment (creatinine level > 1.5 mg/dL). Diagnosis of advanced liver disease indicated in the medical record or by a MELD score of above 10. Women ...